Pharma firm buys treasury shares again for HUF 370 mn.
A report from the Portfolio Energy Investment Forum 2017 conference.
Share price approaches multi-year high.
Performance in quarterly terms not so stellar, though.
Signs exclusive distribution agreement with Prima-Temp.
General Counsel of Mol Group says they can wait.
Federal Supreme Court rejects Croatian appeal.
Rating agency affirms Mol's l-t IDR, with stable outlook.
State aid for Polyol Project is a go.
Long-term and short-term LC deposit ratings upgraded.
Polyol Project revs up.
PKN beats Mol in downstream, though.
For the commercialisation of novel drug in Europe, Latin America and other markets.
Aims to boost market share to 7-8%.
Agreement with trade unions reached.
Guessing game has been on for a while now.
Erik Bogsch will remain Chairman of the Board, though.
Shoots up 150 places.
For incentive programme.
Half-yearly and annual reports will remain.